Clinical Trials Directory

Trials / Completed

CompletedNCT01828593

Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy

Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Study Evaluating the Impact of Serum-derived Bovine Immunoglobulin Protein Isolate, a Medical Food, on Nutritional Status in HIV+ Subjects With HIV-associated Enteropathy.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
103 (actual)
Sponsor
Entera Health, Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate the effectiveness of the oral nutritional therapy serum-derived bovine immunoglobulin protein isolate (SBI) 2.5 g twice a day (BID) and SBI 5.0 g versus placebo on supporting nutrient absorption in HIV+ subjects with HIV-associated enteropathy.

Detailed description

This study is evaluating the effectiveness of the oral nutritional therapy serum-derived bovine immunoglobulin protein isolate (SBI) 2.5g BID and SBI 5.0g compared to placebo for 6 months on gastrointestinal symptoms, nutritional status and quality of life in HIV+ subjects with HIV-associated enteropathy. In addition, the effects of SBI on pro-inflammatory intestinal microbial populations, bacterial translocation, intestinal barrier function, and systemic immune activation will be investigated.

Conditions

Interventions

TypeNameDescription
OTHERSerum-derived bovine immunoglobulin protein isolate (SBI)SBI is a specially formulated light-colored protein powder composed of immunoglobulin (IgG) and other serum proteins similar to those found in colostrum and milk. SBI does not contain any milk products such as lactose, casein, or whey. SBI is gluten-free, dye-free, and soy-free. SBI is manufactured in accordance with current Good Manufacturing Practice (cGMP) and FDA guidelines for medical food ingredients.
OTHERPlaceboMatching placebo

Timeline

Start date
2013-04-01
Primary completion
2014-01-01
Completion
2014-09-01
First posted
2013-04-10
Last updated
2017-06-21
Results posted
2016-03-08

Locations

10 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01828593. Inclusion in this directory is not an endorsement.